February 6, 2026
Sarepta Therapeutics just received approval to begin clinical trials for SRP-1005, an investigational treatment offering new hope to the Huntington's Disease community. This is a significant stride towards potential new therapies! ✨ #HuntingtonsDisease #HDResearch
Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington’s Disease